NCT05443919 - A Clinical Trial to Evaluate the Efficacy and Safety of TwiFlow-System for Acute Pulmonary Embolism | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

December 10, 2022

Study Completion Date

January 10, 2023

Conditions

Pulmonary Embolism

Interventions

DEVICE

TwiFlow-Thrombectomy Catheter System

Patients with acute pulmonary embolism and meeting the conditions of this clinical trial will accept the pulmonary embolism removal operation by the novel device named 'TwiFlow-Thrombectomy Catheter System'.

Trial Locations (1)

210046

Atrial shunt implant system, Nantong

All Listed Sponsors

collaborator

Xiamen Cardiovascular Hospital, Xiamen University

OTHER

lead

Morningside (Nantong) Medical Co.,Ltd

OTHER